AD

Ankit Dhirajlal Raiyani

Active Director Designated Partner DIN 09354904
DIN 09354904 First appointment Oct 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Ankit Dhirajlal Raiyani

Data last updated:

Ankit Dhirajlal Raiyani is a Designated Partner at Qure Hematology And Oncology Center Llp (since 2023). The company operates in Healthcare.

DIN 09354904
Primary Designation Designated Partner
Industry Healthcare
First Appointment 01 Oct 2023
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner01 Oct 20232018Active

Board colleagues of Ankit Dhirajlal Raiyani

Directorship timeline

Open interactive timeline →
Qure Hematology And Oncology Center Llp
Premium access

Shareholding and investment profile for Ankit Dhirajlal Raiyani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankit Dhirajlal Raiyani

Ankit Dhirajlal Raiyani currently holds 1 directorship: Qure Hematology And Oncology Center Llp (Designated Partner, since 01 Oct 2023).

Ankit Dhirajlal Raiyani was first appointed on 01 Oct 2023 as Designated Partner at Qure Hematology And Oncology Center Llp.

The current boards of Ankit Dhirajlal Raiyani's companies include Eva Amit Vyas (Qure Hematology And Oncology Center Llp), Himal Mahipat Shah (Qure Hematology And Oncology Center Llp), Jwalant Sureshbhai Shah (Qure Hematology And Oncology Center Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available